Showing results (181-190 of 213) with videos related to

Sort By:
Pageof 22
Molecular Therapy. Methods & Clinical Development|October 12, 2023
A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infectionStephen Boulton, Joanna Poutou, Rida Gill, et al.
Scientific Reports|May 27, 2016
First-in-class small molecule potentiators of cancer virotherapyMark H Dornan, Ramya Krishnan, Andrew M Macklin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2011
The oncolytic poxvirus JX-594 selectively replicates in and destroys cancer cells driven by genetic pathways commonly activated in cancersKelley A Parato, Caroline J Breitbach, Fabrice Le Boeuf, et al.
Membranes|September 3, 2020
Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces TrimerizationTaha Azad, Ragunath Singaravelu, Mathieu J F Crupi, et al.
Molecular Therapy Oncolytics|December 3, 2016
Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodiesLaura Evgin, Carolina S Ilkow, Marie-Claude Bourgeois-Daigneault, et al.
EMBO Molecular Medicine|July 13, 2010
Oncolytic targeting of renal cell carcinoma via encephalomyocarditis virusFrederik C Roos, Andrew M Roberts, Irene I L Hwang, et al.
Oncoimmunology|June 15, 2018
Transforming the prostatic tumor microenvironment with oncolytic virotherapyMatthew J Atherton, Kyle B Stephenson, Fanny Tzelepis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2014
Maraba MG1 virus enhances natural killer cell function via conventional dendritic cells to reduce postoperative metastatic diseaseJiqing Zhang, Lee-Hwa Tai, Carolina S Ilkow, et al.
The Lancet. Oncology|May 23, 2008
Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trialByeong-Ho Park, Taeho Hwang, Ta-Chiang Liu, et al.
The Journal of Biological Chemistry|April 26, 2023
Inhibition of exchange proteins directly activated by cAMP as a strategy for broad-spectrum antiviral developmentStephen Boulton, Mathieu J F Crupi, Siddharth Singh, et al.
Pageof 22